FDA Adverse Event Injury Summary report: N

OMNIPOD INSULIN PUMP

MDR report key: 15472181 · Received September 23, 2022

Report

Report Number
3004464228-2022-17633
Event Type
Injury
Date Received
September 23, 2022
Date of Event
September 20, 2022
Report Date
September 20, 2022
Manufacturer
INSULET CORPORATION
Product Code
LZG
PMA / PMN Number
K192659
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
MA, US
Reporter Occupation
OTHER
Health Professional
N

Narratives

Additional Manufacturer Narrative · 0

THE DEVICE HAS NOT BEEN RETURNED/RECEIVED TO DATE. IF THE DEVICE IS RECEIVED, A SUPPLEMENTAL REPORT WILL BE SUBMITTED WITH THE INVESTIGATION RESULTS. WE ARE UNABLE TO DETERMINE IF ANY PRODUCT CONDITION COULD HAVE CONTRIBUTED TO THE SKIN IRRITATION LOT RELEASE RECORDS WERE REVIEWED AND THE PRODUCT LOT MET ALL ACCEPTANCE CRITERIA. THE OMNIPOD IS ISO10993 COMPLIANT, UNDERGOING CYTOTOXICITY, SENSITIZATION, GENOTOXICITY, HEMOLYSIS, IRRITATION OR INTRACUTANEOUS REACTIVITY, SYSTEMIC TOXICITY, AND IMPLANTATION EFFECTS TESTING. THE OMNIPOD IS STERILIZED WITH 100% ETHYLENE OXIDE GAS WITH A STERILITY ASSURANCE LEVEL OF 10-6  PER ISO11135  AND EO RESIDUAL LEVELS IN COMPLIANCE WITH ISO10993. EACH LOT  IS CONFIRMED TO MEET REQUIREMENTS FOR NON-PYROGENICITY PER ISO10993 AND STERILITY PER ISO11135 PRIOR TO RELEASE.

Additional Manufacturer Narrative · 0

THE RETURNED DEVICE WAS EVALUATED AND THE INVESTIGATION RESULTS FOUND NO DAMAGES OR MANUFACTURING DEFICIENCIES THAT WOULD CAUSE THE REPORTED IRRITATION AT THE INFUSION SITE. THE EXACT CAUSE OF THE REPORTED EVENT COULD NOT BE DETERMINED. CORRECTION TO D(4): CATALOG NO CHANGED FROM UNAVAILABLE TO ZXP425. CORRECTION TO G(5): PMA/510(K) # CHANGED FROM UNAVAILABLE TO K192659.

Description of Event or Problem · 0

IT WAS REPORTED THAT PATIENT DEVELOPED SKIN IRRITATION, REDNESS, RAW SKIN, BLISTERS AND SCARRING WHILE WEARING THE DEVICE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
2837367 OMNIPOD INSULIN PUMP PUMP, INFUSION, INSULIN LZG INSULET CORPORATION 40160 L50342

Patients

Seq Age Sex Outcome Treatment
1 54 YR Female